glp-1 drugs pharmaceutical companies 2025 Healthcare and Pharma Shifts Driving Drug Delivery Growth in Novo cuts GLP-1 prices 70%,

Daniel Drucker [Biomarker April 2023] Early Days of Weight Loss Therapies Early Days of Weight Loss Therapies In the late 1800s, thyroid extract was used to speed up metabolism and induce weight loss

In the largest clinical trial that tested Wegovy before its FDA approval, people taking the highest dose (2.4 milligrams) lost, on average, more than 12% of their body weight over 17 months

Prepare for more intensive utilization management as indications expand

However, evidence on the cardiovascular benefits of tirzepatide is only emerging and no randomized study has directly compared it to semaglutide 16,17

GLP-1 drugs have been approved by the FDA for diabetes and weight loss, making way for GLP-1 patches for both indications